RAP1B and cancer: As the first platinum (IV) complex that potently inhibits Rap1b and effectively reverses cisplatin-induced drug resistance, complex-1 fills the gap that there is no effective solid molecule inhibitor for Rap1b, and provides a new way of thinking for the development of Rap1b inhibitors and overcoming cisplatin-induced drug resistance in cancer cells (Zhao et al., 2024).